Biogen announce new clinical trial for SCA3
Biogen announce new clinical trial for SCA3 Biogen have announced that they are starting a Phase I clinical trial for their Spinocerebellar Ataxia Type 3 (SCA3) treatment BIIB132. A Phase […]
Biogen announce new clinical trial for SCA3 Read More »